Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai.

Yang ZT, Wu L, Liu XY, Zhou M, Li J, Wu JY, Cai Y, Mao EQ, Chen EZ, Lortholary O.

BMC Infect Dis. 2014 May 6;14:241. doi: 10.1186/1471-2334-14-241.

2.

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.

Ma CF, Li FQ, Shi LN, Hu YA, Wang Y, Huang M, Kong QQ.

BMC Infect Dis. 2013 Jul 22;13:337. doi: 10.1186/1471-2334-13-337.

3.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
4.

Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.

Girão E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EA, Costa SF.

Med Mycol. 2008 Sep;46(6):581-8. doi: 10.1080/13693780802004996.

PMID:
19180727
5.

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.

Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C.

PLoS One. 2011;6(9):e24198. doi: 10.1371/journal.pone.0024198. Epub 2011 Sep 15.

6.

Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.

Chen PY, Chuang YC, Wang JT, Sheng WH, Yu CJ, Chu CC, Hsueh PR, Chang SC, Chen YC.

J Microbiol Immunol Infect. 2014 Apr;47(2):95-103. doi: 10.1016/j.jmii.2012.08.025. Epub 2012 Oct 11.

7.

[Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].

Cao B, Wang H, Wu L, Sun WJ, Li F, Liu YM.

Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1970-3. Chinese.

PMID:
19062737
8.

Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan.

Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, Hashimoto S, Shimizu J, Morita S, Tomono K.

J Infect Chemother. 2014 Sep;20(9):558-62. doi: 10.1016/j.jiac.2014.05.009. Epub 2014 Jul 5.

PMID:
25009091
9.

Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.

Doi AM, Pignatari AC, Edmond MB, Marra AR, Camargo LF, Siqueira RA, da Mota VP, Colombo AL.

PLoS One. 2016 Jan 25;11(1):e0146909. doi: 10.1371/journal.pone.0146909. eCollection 2016.

10.

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.

Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, Diekema DJ.

Diagn Microbiol Infect Dis. 2008 Mar;60(3):273-7. Epub 2007 Nov 19.

PMID:
18024053
11.

Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.

Dotis J, Prasad PA, Zaoutis T, Roilides E.

Pediatr Infect Dis J. 2012 Jun;31(6):557-60. doi: 10.1097/INF.0b013e31824da7fe.

12.

Clinical and therapeutic aspects of candidemia: a five year single centre study.

Bassetti M, Merelli M, Ansaldi F, de Florentiis D, Sartor A, Scarparo C, Callegari A, Righi E.

PLoS One. 2015 May 26;10(5):e0127534. doi: 10.1371/journal.pone.0127534. eCollection 2015.

13.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.

Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.

14.

Risk factors for candidemia-related mortality at a medical center in central Taiwan.

Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW.

J Microbiol Immunol Infect. 2006 Apr;39(2):155-61.

PMID:
16604249
15.

Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T.

Infection. 2014 Apr;42(2):393-404. doi: 10.1007/s15010-013-0570-4. Epub 2013 Dec 19.

PMID:
24352810
16.

Changing epidemiology of candidemia in a medical center in middle Taiwan.

Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY.

J Microbiol Immunol Infect. 2015 Jun;48(3):306-15. doi: 10.1016/j.jmii.2013.08.017. Epub 2013 Oct 8.

17.

Candidemia outcomes not improved with statin use.

Welch ML, Liappis AP, Kan VL.

Med Mycol. 2013 Feb;51(2):219-22. doi: 10.3109/13693786.2012.692490. Epub 2012 Jun 4.

PMID:
22662759
18.

Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.

Lin CC, Liu CP, Hsieh FC, Lee CM, Wang WS.

J Microbiol Immunol Infect. 2015 Oct;48(5):552-8. doi: 10.1016/j.jmii.2014.07.007. Epub 2014 Oct 12.

PMID:
25315213
19.

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.

Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H.

Int J Antimicrob Agents. 2014 Jan;43(1):78-81. doi: 10.1016/j.ijantimicag.2013.09.005. Epub 2013 Oct 12.

PMID:
24182454
20.

Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.

Ortega M, Marco F, Soriano A, Almela M, Martínez JA, López J, Pitart C, Mensa J.

J Hosp Infect. 2011 Feb;77(2):157-61. doi: 10.1016/j.jhin.2010.09.026. Epub 2011 Jan 7.

PMID:
21216030
Items per page

Supplemental Content

Write to the Help Desk